Aim: We evaluated a novel treatment for obesity-related renal, an ATP-citrate lyase (ACL) inhibitor, to attenuate ectopic lipid accumulation (ELA) in the kidney and the ensuing inflammation. Materials ...

Esperion (NASDAQ: ESPR) today announced it will report third quarter 2024 financial results before the market opens on Tuesday, March 4, 2025. Following the release, management will host a webcast at ...

SLC25A1 drives citrate export from the mitochondria to the cytosol, where it fuels acetyl-CoA synthesis by ATP citrate lyase (ACLY). This acetyl-CoA supply sustains FSP1 acetylation and prevents its ...

Esperion (NASDAQ: ESPR) today announced that on February 11, 2025, the Company granted ten new employees 58,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan.

Analysts at Jefferies have suggested the first-in-class ATP citrate lyase (ACL) inhibitor could achieve peak sales in the region of $2-$3 billion, again depending on a cardiovascular outcomes ...

Thraustochytrid is a promising algal oil resource with the potential to meet the demand for docosahexaenoic acid (DHA). However, oils with high DHA content produced by genetic modified ...

A. As of February 2025, Jannik Sinner is the ATP World No. 1. Q. Who won the 2025 Australian Open men's singles title? - + A. A. Jannik Sinner won the 2025 Australian Open men's singles final ...

In this important work, Lodhiya et al. provide evidence that excessive ATP underlies the killing of the model organism Mycobacterium smegmatis by two mechanistically-distinct antibiotics. The data are ...

See schedule and winners of all ATP Tour, ATP 1000 Masters events and Grand Slams in 2025; more than 4,000 tennis matches and 80 tournaments shown live on Sky Sports; Carlos Alcaraz will defend ...